MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202611067083 A) filed by Dr. Ved Pal; Dr. Bindiya Chauhan; Prof. Dr. Suresh Kumar; Dr. Rohit Singh; and Dr. Ratan Deep Chauhan on May 28, 2026, for Nanoencapsulated Tulsi Extract Formulation For Prevention And Treatment Of Respiratory Disorders.
Inventors include Dr. Ved Pal; Dr. Bindiya Chauhan; Prof. Dr. Suresh Kumar; Dr. Rohit Singh; and Dr. Ratan Deep Chauhan.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: ABSTRACT The present invention relates to a nanoencapsulated Tulsi extract formulation for prevention and treatment of respiratory disorders. The invention comprises standardized Ocimum sanctum extract encapsulated within biodegradable nanocarriers to improve pulmonary bioavailability, stability, sustained release, and therapeutic efficacy. The formulation exhibits significant anti- inflammatory, antioxidant, antimicrobial, bronchodilatory, and immunomodulatory activities useful in asthma, bronchitis, COPD, allergic rhinitis, and respiratory infections. The nanoformulation may be administered through inhalational, nebulized, nasal, pulmonary, or oral routes. Experimental studies demonstrated enhanced respiratory protection, reduced airway inflammation, improved lung histopathology, and prolonged therapeutic action compared to conventional herbal extracts. The invention provides a safe, effective, and targeted herbal nanotherapeutic system for respiratory disease management.
Disclaimer: Curated by HT Syndication.
